Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
ALX Oncology Holdings Inc. (ALXO) had Cash Flow from Financial Activities of $-0.16M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-25.95M |
|
-- |
|
-- |
|
$26.65M |
|
$-26.65M |
|
$0.70M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-25.95M |
|
$-26.65M |
|
$-26.70M |
|
53.45M |
|
53.45M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$85.26M |
|
$1.50M |
|
$10.06M |
|
$95.32M |
|
$18.85M |
|
$7.00M |
|
$12.06M |
|
$30.91M |
|
$64.42M |
|
$64.42M |
|
$64.42M |
|
53.51M |
|
| Cash Flow Statement Financials | |
$-48.07M |
|
$49.96M |
|
|
Cash Flow from Financial Activities |
$-0.16M |
$17.63M |
|
$19.37M |
|
$1.74M |
|
$7.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
0.10 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-48.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.28% |
|
-40.28% |
|
-27.22% |
|
-36.34% |
|
$1.20 |
|
$-0.90 |
|
$-0.90 |
|